Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Acta Neurol Scand. 2010 Feb;121(2):109-13. doi: 10.1111/j.1600-0404.2009.01243.x. Epub 2009 Sep 10.
Mitochondrial DNA (mtDNA) mutations are increasingly being recognized as causes of late-onset disease. We report a patient with a late-onset mitochondrial encephalomyopathy caused by a novel G > C transition in mtDNA at position 5556 in the gene encoding the tRNA for tryptophan (MTTW).
To investigate the cause of disease and assess the pathogenicity of this new mutation.
Clinical, histopathological and gene sequencing studies. Quantification of the mutation was performed in different tissues from the patient and two relatives and in single muscle fibres.
The mutation was heteroplasmic, segregated in biochemically affected muscle fibres and was absent in blood. The level of mutation in skeletal muscle was higher than in brain, although the brain was clinically the most affected tissue.
The 5556G > C mutation appears sporadic. It was not found in any of the family members tested, although some of them manifested disorders that can be associated with mtDNA disease. In addition to reporting the eighth mutation in MTTW, our case illustrates the challenges posed when assigning pathogenicity to mtDNA mutations.
线粒体 DNA(mtDNA)突变越来越被认为是导致迟发性疾病的原因。我们报告了一例由编码色氨酸 tRNA(MTTW)的基因中 mtDNA 第 5556 位 G > C 转换引起的迟发性线粒体脑肌病患者。
探讨疾病的病因,并评估该新突变的致病性。
进行临床、组织病理学和基因测序研究。在患者和两位亲属的不同组织以及单个肌肉纤维中定量检测突变。
该突变呈异质性,在生化受影响的肌纤维中分离,并在血液中缺失。骨骼肌中的突变水平高于脑,但脑是临床上受影响最严重的组织。
5556G > C 突变似乎是散发性的。虽然一些家庭成员表现出可能与 mtDNA 疾病相关的疾病,但在测试的所有家庭成员中均未发现该突变。除了报告 MTTW 的第八个突变外,我们的病例还说明了在将 mtDNA 突变归因于致病性时所面临的挑战。